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Abstract: Vertical arrays of nanostructures can direct access to cell cytoplasma and probe 36 
intracellular molecules. Here, we report an efficient cytosolic delivering platform by simply 37 
combining diamond nanoneedle arrays with centrifugation-induced supergravity. We prove 38 
that diamond nanoneedle arrays can efficiently deliver drugs and biomaterials into cytosol 39 
within several minutes, negotiating the endocytososomal system on cytomembrane. More 40 
importantly, we studied the potential influence of the technique on cell metabolism. By 41 
detecting the phosphorylated histone variant H2AX (pH2AX) in the nucleus, we prove that 42 
the operating process will not lead to DNA double-strand breaks. However, the mechanical 43 
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disruption can temporarily improve the permeability of the cell membranes. Furthermore, we 1 
find that nanoneedle treatment can affect the metabolism in living cells. The treatment can 2 
slightly elevate the apoptotic signal in A549 cells. The diamond nanoneedle array treatment 3 
can significantly increase the production of reactive oxygen species (ROS) in cells, 4 
particularly when working together with anticancer drug molecules. Meanwhile, the activity 5 
of cytosolic glucose 6-phosphate dehydrogenase (G6PD) is also raised to counterbalance the 6 
elevated ROS content. The result of the marked depolarization of mitochondrial membrane 7 
potential suggests that mitochondrial have involved in the intracellular redox reactions and 8 
cell apoptosis, which are induced by diamond nanoneedle treatment. Overall, we 9 
systematically investigate the potential influence of diamond nanoneedle arrays treatment on 10 
the physiology of cells and this study provides a novel understanding on the intracellular 11 
delivery mediated by nanoneedles.  12 
 13 
1. Introduction 14 
Delivery of biological molecules and fluorescent probes into living cells and tissues is of great 15 
importance.[1,2] A broad range of cationic polymers, lipids, transfection and complex-16 
assembling reagents, as well as nanomaterials have been widely used in cytosolic delivery.[3-11] 17 
However, many factors affect the efficiency of cargo molecules delivery, such as cell type, 18 
cell number, media, carrier-relating cytotoxicity and low transfection efficacy for hard 19 
transfecting cells.[12,13] Recently, as a physical approach, vertical nanostructure arrays are 20 
reported to conveniently facilitate intracellular delivery with high throughput.[14] For example, 21 
vertical silicon nanowires have been developed as a universal platform for transporting a 22 
range of cargos into living cells, including DNAs, RNAs, peptides and proteins.[3,15] In the 23 
delivering process, cells are cultured on the vertical nanostructures for a period of time so that 24 
the nanowires spontaneously penetrate cell’s membranes and the pre-coated biomolecules on 25 
the nanostructures can be slowly released into the cells. Similarly, aluminium oxide 26 
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nanostraws have also been applied to deliver cargos into cells but the difference is that the 1 
nanostraws are hollow and integrated with a reservoir so materials can be directly injected to 2 
cells once the nanostraws pierce into cells during the culturing.[16] The advantage of these 3 
methods is that biomolecules can be transported into cells without the requirement of 4 
chemical modification or viral packaging. However, some cell functions might be perturbed 5 
by culturing on such nanostructures for extended period of time. For example, it has been 6 
discovered that HeLa cells grow slowly[17] and temporarily develop irregular contours when 7 
culturing on silicon nanowires and the penetration of nanowires into cells leads to lipid 8 
scrambling although this can be reversed in healthy cells.[15] In addition, Persson et al. 9 
explored that fibroblasts cultured on similar nanostructures display impaired cell division, 10 
increased reactive oxygen species (ROS) content and ultimately DNA damage.[18] Liu et al. 11 
found that mesenchymal stem cells exhibit significantly different adhesion, proliferation and 12 
differentiation behavior when compared to those on flat substrates.[19] 13 
To alleviate these problems, we developed diamond nanoneedle arrays for enhanced 14 
intracellular delivery.[20-22] In our approach, instead of culturing cells on the vertical 15 
nanostructures for spontaneous penetration over a period, we allow the nanoneedles to 16 
actively disrupt the cell membranes within a very short duration (e.g., seconds to minutes) by 17 
a precisely controlled centrifugation force or applying a cell suspension to the nanostructures 18 
with a certain speed.[20-22] This platform has been demonstrated capable of effectively 19 
delivering fluorescent cell probes (iridium(III) polypyridine complex, FITC-dextran, 20 
propidium iodide (PI), and calcein AM, semiconductor quantum dots), drug molecules 21 
(cisplatin), and genes (siRNA and DNA) to various cell lines.[20,21,23] Very recently, with a 22 
similar manner, carbon nanosyringe arrays have also been employed to facilitate the delivery 23 
of bioactive molecules to hard-to-transfect cells.[24] Beyond these in vitro uses on cell lines, 24 
biodegradable silicon nanoneedles with 50-nm-diameter tips are applied in vivo to transfect 25 
VEGF-165 gene and induce sustained neovascularization.[25] This work sets a new milestone 26 
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in the application of nanoneedle arrays for delivering biological functional molecules to the 1 
cells in living tissues. 2 
Despite the promising future of this new approach, the effect of the method on cell 3 
physiology has not been investigated although it is of great importance to the design of the 4 
nanostructures and operation parameters. In this study, we apply cells in a suspension to 5 
diamond nanoneedle arrays with centrifugation force for efficient intracellular delivery and 6 
then investigate the potential influence of the method on cell’s DNA, ROS content, 7 
mitochondrial membrane potential and glucose-6-phosphate dehydrogenase (G6PD) activity. 8 
These findings will certainly improve our understanding of the technology of using this type 9 
of vertical nanostructures for intracellular delivery and should provide guidance to better 10 
design the platform for practical applications. 11 
 12 
2. Results and discussion 13 
2.1. Fabrication of diamond nanoneedle arrays 14 
Diamond nanoneedle arrays were fabricated by forming a polycrystalline diamond thin film 15 
first on silicon substrates followed by microwave plasma etching. We specifically chose 16 
diamond to manufacture nanoneedle arrays because of its outstanding mechanical strength 17 
and inertness. Two representative SEM images of diamond nanoneedle arrays are shown in 18 
Figure 1a. These nanoneedles are conical in shape with height of 2 μm and density of 1 × 106 19 
mm-2. The tip of diamond nanoneedle arrays is about 50 nm. 20 
2.2. Diamond nanoneedle arrays to facilitate intracellular delivery 21 
In our previous reports[20,22], we used diamond nanoneedle arrays to improve intracellular 22 
delivery by applying a cell suspension to the nanostructures with a certain speed. The method 23 
is high-throughput and effective but lack of precise control. To further improve this approach, 24 
herein, we apply a cell suspension on a diamond nanoneedle arrays and then apply 25 
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centrifugation force to carefully control the interaction between cells and nanostructures for 1 
enhanced intracellular delivery (Figure 1b). At the end of the process, the cell suspension is 2 
collected. 3 
Before measuring the potential influence of the technology on cell physiology, we firstly 4 
proved that this system could be used to rapidly transport fluorescent molecules into cells. In 5 
our experiment, we chose FITC labelled dextran with large molecular weight of 10,000 6 
Daltons for this evaluation and the results are presented in Figure 2a. Three groups were 7 
performed including untreated cells, cells incubated with FITC-dextran without nanoneedles 8 
treatment, and cells treated with both nanoneedles and FITC-dextran. From the figures, it can 9 
be observed that the untreated cells and the cells incubated with FITC-Dextran for minutes 10 
but without nanoneedles treatment display no or negligible fluorescence. In great contrast, 11 
FITC-dextran is able to quickly transport into the nanoneedles treated A549 cells within only 12 
5 minutes. Calculated by the software Image J, the relative fluorescence intensities in the cells 13 
without and with diamond nanoneedle application are 10% and 57%, respectively (Figure 2b). 14 
After confirming that the method can effectively deliver fluorescent molecules into cells, 15 
we then investigated whether this method was capable of improving the delivery of 16 
biologically functional small molecules to cells. Tests on three groups were conducted. In one 17 
group, 0.2 μg ml-1 of cisplatin was added into cell suspension and then the cells were placed 18 
on a diamond nanoneedle substrate followed by application of centrifugation force of 30 19 
seconds only. Following that, the treated cells were cultured for 48 hours for viability 20 
measurement. Another group was A549 cells in a suspension containing the same 21 
concentration of cisplatin but without nanoneedle treatment. Untreated A549 cells were used 22 
as negative control group. The cell viability of all three groups was measured 48 hours later. 23 
The results were normalized to the number of cells in the negative control group. Compared 24 
with the negative control group, there was no reduction of cell viability observed in the group 25 
of cells treated with cisplatin but without nanoneedle treatment. It indicates that the 26 
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concentration of cisplatin is very low and not enough to kill cells. However, with additional 1 
nanoneedle treatment, the viability of cells dramatically drops by 32% in the presence of the 2 
same concentration of cisplatin (Figure 2c). Considering that the duration of nanoneedle 3 
treatment time might affect the drug delivery efficiency, we tested the cell viability by 4 
increasing the centrifugation time from 30 seconds to 5 minutes. As shown in Figure 2d, the 5 
viability of cells decreases over 60%. Overall, the results in Figure 2 demonstrate that this 6 
method is efficient in intracellular delivery. 7 
Since the nanoneedle platform has been proved to be an efficient system in cytosolic 8 
delivery, we also expect that diamond nanoneedle arrays can enhance the delivery of drugs 9 
into drug resistant cells. We tested the potential efficiency of this system in doxorubicin 10 
resistant MCF7 cell line (MCF7/ADR) by flow cytometry. Three groups were conducted in 11 
the experiment. The first group of untreated MCF7/ADR cells was used as a negative control 12 
group. The second group of MCF7/ADR cells was incubated with 2 μg ml-1 doxorubicin for 5 13 
minutes. The third group of cells was treated by both nanoneedles and doxorubicin at the 14 
same time. The results are described in Figure 2e. It can be seen that the efficiency of 15 
MCF7/ADR doxorubicin delivery in the diamond nanoneedle arrays group (27.53%) is higher 16 
than that in the doxorubicin free-delivery group (17.11%). The fluorescent intensity of 17 
doxorubicin in control group is only 5.6%. Furthermore, we also evaluated the use of 18 
nanoneedle treatment in helping doxorubicin to kill MCF7/ADR cells. When MCF7 cells are 19 
cultured with 1 μg ml-1 doxorubicin for 48 hours, the cell viability is only about 10% (Figure 20 
S1, Supporting Information). In comparison, for MCF7/ADR cells, this dose is even not 21 
strong enough to induce significant cell death. Attractively, with the aid of diamond 22 
nanoneedle arrays treatment, the viability of MCF7/ADR cells can be reduced to about 50% 23 
(Figure 2f) in the presence of the same concentration of doxorubicin. Collectively, these 24 
results suggest that diamond nanoneedle arrays be an efficient delivering platform even for 25 
drug resistant cells. 26 
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2.3. Toxicity of diamond nanoneedle array treatment 1 
While confirming that diamond nanoneedle treatment is able to facilitate the transport of 2 
molecules into cells and improve the efficacy of drugs, the next key question is whether the 3 
methodology leads to cytotoxicity. 4 
To investigate if our intracellular delivery approach has any impact on cell proliferating 5 
ability, we firstly performed a viability study of cells. One group of untreated cells was used 6 
as a control group. The other group of cells was treated with diamond nanoneedle arrays by 7 
centrifugation at 120 g for 5 min at room temperature. The total number of cells at the 8 
beginning of the experiments in each group is about 30,000. Then the cell viabilities of both 9 
groups of cells were determined with an MTT assay and the results are shown in Figure 3a. It 10 
is clear that the diamond nanoneedle arrays treatment does not cause measurable cell death in 11 
comparison with the untreated cells. 12 
Following cytotoxicity measurement, to find out whether our approach induces DNA 13 
damage, we investigated the integrity of genomic DNA in cells. One response to double 14 
strand DNA break is the need of phosphorylated histone variant H2AX (pH2AX) in the 15 
recruitment of proteins responsible for DNA repairing.[26, 27] In other words, the pH2AX 16 
indicates DNA double-strand breaks. Therefore, we measured the level of DNA damage by 17 
specific antibody-based detection of pH2AX in nucleus. In the test, cells were treated by 18 
diamond nanoneedle arrays followed by culturing in a 96-well plate for 3, 6 and 24 hours.  19 
Untreated cells were again used as a negative control group. Then all of the groups of cells 20 
with different culturing times were labelled with pH2AX mouse monoclonal antibody.   21 
Subsequently, a fluorescent secondary antibody was used to bind to the primary pH2AX 22 
antibody and the fluorescence intensities were determined for quantity analysis of pH2AX.  23 
As shown in Figure 3b, the amount of pH2AX does not have significant difference between 24 
the control group and the group treated by nanoneedle arrays at all 3 different time points. 25 
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This indicates that the diamond nanoneedle array treatment does not lead to DNA double-1 
strand breaks. 2 
Besides genotoxicity, we also measured the integrity of cytoplasm membrane at 3, 6, and 3 
24 hours after diamond nanoneedle array treatment with the image-iT dead green viability 4 
stain. We previously demonstrated that diamond nanoneedle disruption to cells can lead to the 5 
permeation of ethidium homodimer-1 (EthD-1) through the cell membranes.[21] EthD-1 is a 6 
high-affinity nucleic acid stain that is weakly fluorescent until bound to DNA and emits red 7 
fluorescence. In the test, EthD-1 was applied when cells were undergoing nanoneedle 8 
treatment. However, here, we add Image-iT dead green at 3, 6, and 24 hours after nanoneedle 9 
treatment. Image-iT dead green staining is a microscopy-based fluorescent assay for dead 10 
cells. It is impermeable to health cells but become permeant when the cytoplasm membrane is 11 
compromised. The result about image-iT dead green staining is presented in Figure 3c. It is 12 
clear that there is negligible difference of fluorescence intensity between the untreated cells 13 
and the group treated by nanoneedle arrays at different time points, suggesting that the cell 14 
membranes recover their integrity soon after nanoneedle disruption (Figure 3c). 15 
We next monitored the release of glucose 6-phosphate dehydrogenase (G6PD) from 16 
treated cells into the surrounding medium. G6PD is a cytosolic enzyme and can leak from 17 
dead cells. The released amount of G6PD in cell medium correlates with the number of dead 18 
cells in the sample. Since the level of G6PD activity in common cell culture sera is much 19 
lower than many other enzymes, such as lactate dehydrogenase, this assay can be more 20 
precise and effective. A549 cells were treated with a diamond nanoneedle arrays following by 21 
24 hours culturing in a 96-well plate. The extracellular G6PD level was detected by following 22 
the vibrant cytotoxicity assay kit. The mechanism is to oxidise glucose 6-phosphate by G6PD 23 
and generate NADPH, which cause the reduction of resazurin (a blue dye) to yield fluorescent 24 
resorufin for measurement. Cell culture medium and untreated cells were used as two control 25 
groups. The result shows that there is no significant difference among these three groups in 26 
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the amount of extracellular G6PD (Figure 3d). These findings suggest that diamond 1 
nanoneedle treatment delivering system not affect the viability of the cells. This is in line with 2 
the result shown in Figure 3a. 3 
2.4. Nanoneedle treatment leads to apoptosis 4 
After confirming that diamond nanoneedle treatment does not cause measurable necrosis and 5 
DNA damage and the cell membrane integration at 3 hours after treatment is also not affected, 6 
we then investigate whether the nanoneedle will lead to cell apoptosis and influence the 7 
intracellular G6PD level.  8 
For cell apoptosis measurement, A549 cells were treated with a diamond nanoneedle 9 
array followed by culturing for 24 hours. Subsequently, the cells were tested by alexa fluor 10 
488 annexin V/dead cell apoptosis kit. Annexin V was used as a probe to monitor apoptotic 11 
signals. In apoptosis, phosphatidylserine is exposed to the external cellular environment 12 
through lipid scrambling and annexin V can specifically bind to phosphatidylserine for 13 
detection of apoptosis of living cells. Red-fluorescent PI was used to stain cells in the early 14 
stage of necrosis by permeating the cell membranes and binding to nucleic acid within cells.  15 
Similar with the results shown in Figure 3, it can be seen from Figure 4a and 4b that diamond 16 
nanoneedle treatment alone does not induce notable cell death. Comparing to the control 17 
group (Figure 4a) (2.21%), the population of early necrotic cells in the groups of cells treated 18 
by a diamond nanoneedle array were low (1.57% in Figure 4b (cells were treated by a 19 
diamond nanoneedle array alone); 0.71% in Figure 4d (cells were treated by a diamond 20 
nanoneedle array and 5 μg ml-1 cisplatin). However, the total population of apoptotic A549 21 
cells in the nanoneedle treated group slightly increases from 1.31% to 3.17% (Figure 4a, b).  22 
Furthermore, when A549 cells are incubated with 5 μg ml-1 of cisplatin, the population of 23 
apoptotic A549 cells is 11.54%.  When the cells are treated by nanoneedles and cisplatin at 24 
the same time, the population of apoptotic cells will increase to 16.59%.  This also indicates 25 
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the drug efficacy of cisplatin is enhanced through the aid of nanoneedle treatment. In brief, 1 
the results show that nanoneedle treatment slightly induces cell apoptosis. 2 
2.5. The recovery of mechanical disruption on the permeability of cells 3 
The enhanced intracellular delivery results (Figure 2), together with the apoptotic experiments 4 
(Figure 4) suggest the disruption on the cell membrane induced by nanoneedle treatment. In 5 
the meantime, the toxicity test (Figure 3) proves the integrity of the cytomembrane after 6 
diamond nanoneedle treatment. Therefore, it is useful to investigate the recovery process of 7 
the cell membrane after being treated with nanoneedles. This will also provide guidance on 8 
the application of the device.  9 
For this purpose, calcein-AM and PI were chosen to stain the treated cells. Calcein-AM is 10 
highly lipophilic and cell membrane permeable dye which can generate calcein from calcein-11 
AM by esterase in a living cell and emit green fluorescence (maximum excitation: 490 nm, 12 
emission: 515 nm). Therefore, calcein-AM can only stain living cells.  PI is not permeant to 13 
living cells, and therefore has been commonly used to detect the cells with comprised 14 
membranes such as dead cells. To understand the recovery of the cell membrane after 15 
nanoneedle disruption, calcein-AM and PI were added into the medium of the treated cells at 16 
different time points. The group without diamond nanoneedle treatment was set as a control 17 
group. In the control group, a certain number of calcein-AM molecules can enter the cells, but 18 
nearly no PI is able to diffuse to the cells because of the integrity of the cell membranes. 19 
Comparing with the control group, the cytosolic delivery of calcein-AM is dramatically 20 
enhanced when it was added immediately (0 min) after the cells being treated by nanoneedles 21 
(Figure 5a). This is within our expectation as the diamond nanoneedle treatment is supposed 22 
to improve the permeability of the cell membrane. With the increase of the time, the cell 23 
membrane should gradually recover and therefore the permeation of molecules into the cells 24 
should slowly drop. After a certain period of time, the cell membrane is expected to 25 
completely recover, so the permeation of PI molecules into cells should not be possible any 26 
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more.  In line with this theory, we indeed find that the fluorescence intensity of the cells has 1 
the highest value at 0 min. When calcein AM was added at 5, 10 and 20 mins after the cells 2 
being treated by nanoneedles, the fluorescence intensities slightly drop because fewer 3 
molecules are able to enter the cells. When calcein AM was added at 40 mins or later, the 4 
fluorescence intensities fall to the level which is consistent with that of the control group 5 
(Figure 5a, b). This means that the cell membrane should have recovered its integrity. These 6 
findings are in fact fully supported by the PI staining result. For example, when PI was added 7 
to the medium at 40 mins or later, negligible PI molecules can enter the cells, so the 8 
fluorescence can hardly be observed in the cells. We also calculate the percentages of PI 9 
positive cells at each time point. The results indicate that the percentage of PI positive cells 10 
are all above 90% within the 20 minutes period after nanoneedle treatment, but the value 11 
dramatically drops to negligible amount (control level) at 40 minutes. Taking together, we 12 
suggest that diamond nanoneedle arrays penetration indeed disrupts cell membrane, but the 13 
integrity of the cell membrane can recover within 40 minutes of nanoneedle treatment 14 
gradually. 15 
2.6. Nanoneedle treatment produces high content of ROS  16 
In order to examine the ROS content in cells, we used CellROX Green reagent. The dye is 17 
weakly fluorescent in a reduced state but displays high intensity of green fluorescence when 18 
oxidized by ROS. Untreated cells without staining were used as a negative control. The ROS 19 
content of cells was tested at two time points (12 and 24 hours after treatment) under different 20 
conditions. As shown in Figure 6a, after 24 hours incubation, the relative fluorescent 21 
intensity of ROS in A549 cells treated with 1 μg ml-1 of cisplatin is 7.21. In contrast, the 22 
nanoneedle-treated cells had ROS levels of 14.03 and 15.18 at 12 and 24 hours, respectively, 23 
after treatment. When cells were treated by nanoneedles and cisplatin, the ROS levels of 24 
A549 cells were elevated to 16.72 and 23.77 at 12 and 24 hours, respectively, after treatment. 25 
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From the fluorescence images shown in Figure 6b, we can see that, after 12 or 24 hours 1 
incubation, nanoneedle array treatment could obviously elevate intracellular ROS production. 2 
2.7. Nanoneedle treatment induces increased intracellular G6PD level 3 
The results in Figures 4 and 6 show that nanoneedle treatment leads to slightly increased 4 
apoptosis and higher ROS contents. When cells are jointly treated by nanoneedles and drug 5 
molecules (e.g., cisplatin), these findings may partially explain the reason of the improved 6 
drug efficacy when aided with nanoneedle treatment. However, according to our previous 7 
cytotoxicity measurement, the nanoneedle treatment alone will not lead to measurable cell 8 
death with MTT assay. We speculate that the elevated ROS level and apoptosis signal could 9 
trigger the redox components to counteract the negative effect of nanoneedle treatment to the 10 
physiology of the cells. The intracellular redox potential is determined by the ratio of oxidants 11 
and reductants. Nicotinamide adenine dinucleotide phosphate (NADPH) is the principal 12 
intracellular reductant that can be used by many enzymes for reducing power in cells such as 13 
glutathione reductase and catalase.[28] G6PD is the first and rate-limiting enzyme of pentose 14 
phosphate (PP) signal pathway to determine the NADPH production by controlling the 15 
metabolism of glucose via PP signal pathway.[29] G6PD and NADPH have an essential role to 16 
counterbalance the oxidative stress and protect cells from oxidative stress-induced 17 
apoptosis.[30-32] To monitor the intracellular G6PD levels, A549 cells were treated with a 18 
diamond nanoneedle array and the measurement was performed at 3, 6, 12 and 24 hours after 19 
the treatment. For untreated cells, the test was also carried out at all different time points for 20 
comparison. As shown in Figure 7, compared with the control groups, the intracellular G6PD 21 
level in A549 cells are dramatically increased with time increasing and reaches the highest 22 
level at 12 hours and slowly drops to normal level after 48 hours culture. (Figure S5, 23 
Supporting Information). However, combining with the result shown in Figure 4, we 24 
speculate that the increased G6PD activity still could not completely balance the high ROS 25 
content, and therefore the treatment still led to slight elevation of apoptosis signal pathway. 26 
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2.8. Depolarization of mitochondrial membrane potential 1 
After knowing that the diamond nanoneedle array treatment can cause the production of ROS, 2 
we next studied the possible reasons. Mitochondria is an important organelle that plays a 3 
central role in cellular viability, such as heat generation, cell growth, cell death via apoptosis, 4 
passive proton leak, formation and degradation of ROS.[33-37] Via different experimental 5 
models, it has been repeatedly demonstrated that a lower mitochondrial membrane potential is 6 
observed with a simultaneously increase of ROS production.[38, 39] In this study, we used the 7 
MitoProbe JC-1 assay kit to test mitochondrial membrane potential. JC-1 is a lipophilic dye 8 
and can selectively enter into mitochondria with a reversible change of color from green (529 9 
nm) to red (590 nm) as the membrane potential increases. The mitochondrial membrane 10 
potential was detected at three different time points (0, 12 and 24 h). At first, the ratio of 11 
red/green (R3/R2) decreases immediately after the nanoneedle arrays treatment. But after 12 12 
hours, or longer (24 hours), the mitochondrial membrane potential recovers to normal ratio 13 
when compared with control group (Figure 8). This indicates that the depolarization of 14 
mitochondrial membrane potential could be one of the reasons of the generation of ROS. 15 
However, some production of non-mitochondrial ROS could not be completely excluded, 16 
such as the membrane-bound NADPH oxidase[40]. Further experiments will be necessary to 17 
understand the generation of ROS and its influence on the cell physiology.  18 
 19 
3. Conclusion 20 
In summary, our results show that centrifugation force regulated diamond nanoneedle 21 
treatment of cell suspensions could deliver molecules into cells in an efficient way. 22 
Attractively, the approach does not induce noticeable cytotoxicity indicated by the viability of 23 
nanoneedle array treated cells and genotoxicity suggested by the lack of pH2AX expression. 24 
However, the treatment leads to increased ROS content and cell apoptosis. The elevated 25 
Annexin V binding to the cell membranes, shown by the increased apoptosis of cells, reveals 26 
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that diamond nanoneedle array disruption can induce lipid scrambling and then affect the 1 
intracellular metabolic signal pathways. For the cells only treated by our nanoneedle arrays, 2 
these do not induce much cytotoxicity. The reason might be that their damaging to the cells is 3 
partially counteracted by the elevation of G6PD. It is possible that the production of ROS 4 
content during nanoneedle array treatment is partially caused by the decreased mitochondrial 5 
membrane potential (Figure 9). Importantly, by using calcein-AM and PI double staining, we 6 
explored that the cell membranes should fully recover within 40 minutes after diamond 7 
nanoneedle treatment. 8 
In summary, this is the first report in which we systematically investigated the influence 9 
of diamond nanoneedle array treatment on the metabolic signal pathways of cells. It could 10 
provide a new arena for exploiting the nanoneedle application. 11 
 12 
4. Experimental 13 
Fabrication of diamond nanoneedle arrays: Diamond nanoneedle arrays were produced 14 
by a top-down method. Firstly, polycrystalline diamond thin film was fabricated by 15 
Microwave Plasma Chemical Vapor Deposition (MPCVD). N-type silicon wafer (100) –16 
oriented, 1-10 Ω, was polished with diamond particle paste (0.25 μm) was used as a substrate. 17 
Silicon substrate was then put into ultrasonic bath with alcohol and acetone for cleaning.  18 
The ASTeX MWCVD reactor connected with a 1.5 kW microwave generator was 19 
accounted for deposition of polycrystalline diamond film. Methane (CH4) and hydrogen (H2), 20 
in the ratio 1% and 99% were being used as gas precursor, with the total flow rate of 300 21 
SCCM. The temperature, pressure and microwave power were maintained at 800 oC, 30 Torr 22 
and 1200 W, respectively, for 24 hours. Secondly, after synthesis of diamond film, it was 23 
etched to diamond nanocone arrays by using Electron cyclotron resonance Microwave Plasma 24 
Chemical Vapour Deposition (ECR-MPCVD). Around 875G B-field were generated by an 25 
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external magnetic coil to the centre of the chamber. Gases mixture of 70% He, 25% Ar, 5% 1 
N2 were used to induce plasma by 1400 W microwave source. The temperature and pressure 2 
were kept at 400 oC and 2×10-3 Torr, respectively. 3 
Cell cultures: A549 cells (ATCC) were maintained in Dulbecco’s modified Eagle 4 
medium (DMEM, Life Technology) supplemented with 10% fetal bovine serum Hyclone, L-5 
glutamine and 1% penicillin/streptomycin at 37 oC with 5% CO2. Doxorubicin resistant 6 
MCF7 cell line (DR-MCF7) was cultured in full medium with the addition of 2 μg ml-1 7 
doxorubicin (Sigma) for achieving doxorubicin resistance. 8 
Diamond nanoneedle arrays to facilitate intracellular delivery: Adherent cells were 9 
firstly trypsinized to obtain a cell suspension. Then the cell suspension was placed onto a 10 
diamond nanoneedle array located in a 24-well cell culture plate (2×104 cells per well) 11 
followed by centrifugation at 120 g for 5 min at room temperature (CT15RT Eppendorf, 12 
German). This is the standard nanoneedle treatment condition in this paper unless otherwise 13 
specified. The experiments were performed in 3 groups for each cargo material of cisplatin 14 
and dextran-FITC. The first and second group contained cargo molecules of cisplatin (or 15 
dextran-FITC), but only one group of cells experienced diamond nanoneedle treatment. The 16 
third group did not have any cargo molecules and acts as an untreated negative control. In this 17 
paper, untreated control group means that the cells were not treated with centrifugation. After 18 
centrifugation, the cell suspension was removed from the diamond nanoneedle arrays and then 19 
harvested for subsequent operations. 20 
Cytotoxicity assay: The releasing level of glucose 6-phosphate (G6PD) was measured by 21 
the G6PD release assay kit (Invitrogen, USA). Briefly, after nanoneedle treatment, cells were 22 
transferred to a 96-well plate and cultured for 6 hours in a volume of 50 μl. Then 50 μl of 23 
resazurin was added into the plate to a concentration 15 μM. After 10-30 minutes incubation 24 
at 37 oC, the fluorescence intensity was read by a fluorescence microplate reader (BMG 25 
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Polarstar Optima, Ortenberg, Germany) with appropriate excitation (530-560 nm) and 1 
emission filters (580-600 nm). 2 
Cell viability was tested by MTT assay. After nanoneedle treatment, cells were 3 
transferred into a 96-well plate and cultured for 48 hours at 37 oC. Then the medium was 4 
removed and replaced with 100 μl of fresh culture medium containing no cargo molecules. 10 5 
μl of 12 mM MTT stock solution was added into each well followed by incubation at 37 oC 6 
for 4 hours. Subsequently, all media were removed and replaced with 100 μl DMSO. Finally, 7 
the absorbance at 540 nm of each sample was measured by a UV-Vis-IR microplate reader 8 
(Powerwave XS MQX200R, Leicestershire, England).  9 
Flow cytometry: The apoptosis assay was conducted according the protocol of Alexa 10 
Fluor 488 annexin V/dead cell apoptosis kit (Invitrogen, Carlsbad, USA). A 488 nm laser 11 
served as an exciting source for annexin V-FITC (FL1, 530/30 nm) and PI (FL2, 575/24 nm) 12 
(BD FACSCalibur, flow cytometer). 13 
For studying the delivery of doxorubicin into MCF/ADR cells, three groups were 14 
conducted. The first group of MCF7/ADR cells was incubated with 2 μg ml-1 doxorubicin for 15 
5 minutes without diamond nanoneedle treatment. The second group was treated by diamond 16 
nanoneedle arrays for 5 minutes with the addition of 2 μg ml-1 doxorubicin. Untreated 17 
MCF7/ADR cells were used as control. Then three groups of cell suspension were collected 18 
and washed by PBS for two times to remove the extra doxorubicin and re-suspended in PBS 19 
for flow cytometry analysis with excitation at 488 nm and emission filter at 580 nm.  20 
ROS was measured by the CellROX Green Reagent (Invitrogen, Carlsbad, USA) in 21 
living cells. CellROX green reagent was added into a medium to a final concentration of 5 22 
μM and incubated with cells for 30 minutes at 37 oC. Then cells were washed for three times 23 
with PBS for flow cytometry studying (EX/EM 488/520 nm).  24 
Fluorescent microscopy: After centrifugation, cells delivered with dextran fluorescent 25 
488 (10,000 MW, Invitrogen, Carlsbad USA) were incubated with 2 μl of 20 mM 26 
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Hoechst33342 (Invitrogen, Carlsbad, USA) for 20 minutes for nuclei staining at 37 oC. 1 
Cellular fluorescence was monitored using fluorescence microscopy. 2 
   pH2AX detection and Image-iT Dead Green staining: The level of pH2AX was measured 3 
by HCS DNA damage kit (Invitrogen, Carlsbad, USA) with the following procedures. First, 4 
after being treated by a diamond nanoneedle array, cells were transferred to a 96-well plate 5 
and cultured for 3, 6 or 24 hours. Second, the cells were stained with image-iT Dead Green 6 
viability stain working solution for 30 minutes at 37 oC. Third, the cells were fixed with 4% 7 
paraformaldehyde solution for 15 minutes, washed with PBS and incubated with a 8 
permeabilization solution of 15 l of Triton X-100 to 6 mL PBS at room temperature. Fourth, 9 
the samples were washed with PBS and incubated with blocking buffer containing 1% BSA 10 
for 60 minutes. Fifth, the samples were incubated with the primary pH2AX antibody for 60 11 
minutes and washed with PBS for three times. Sixth, the secondary antibody Alexa Fluor 555 12 
goat anti-mouse IgG (H+L) was added and incubated for another 60 minutes. Seventh, the 13 
secondary antibody was removed and the cells were rinsed with PBS. Eighth, 100 μl of fresh 14 
PBS was added into each well for analysis. The samples were scanned by microplate reader 15 
(BMG Polarstar Optima, Ortenberg, Germany) with filters appropriate for Hoechst (350/461 16 
nm), Image-iT Dead Green viability stain (488/515 nm) and Alexa Fluor 555 goat anti-mouse 17 
IgG (555/565 nm).  18 
Calcein-AM and PI staining: After being treated by the diamond nanoneedle arrays, 19 
A549 cells were suspended in PBS. Calcein-AM and PI were added into the cell suspensions 20 
at different time points and incubated at 37 oC for 20 minutes. Then the cells were washed by 21 
PBS for two times and the cellular fluorescence was monitored by fluorescence microscopy 22 
and analysed with ImageJ. A549 cells without nanoneedle treatment were set as a control 23 
group. 24 
Statistical Analysis: Experiments were repeated at least three times. For each set of the 25 
experiments, results were expressed as mean values ± standard deviation. Statistical 26 
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significance was calculated by either the student t-test for paired comparisons or the one-way 1 
ANOVA for multiple comparisons. A p-value < 0.05 was considered as significance. 2 
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Figure 1. (a) SEM images of diamond nanoneedle arrays. The scale bars indicate 5 (left) and 3 
2 μm (right). (b) Schematic representation of diamond nanoneedle mediated intracellular 4 
delivery with centrifugal g-force application. A cell suspension is applied to the surface of a 5 
diamond nanoneedle array and then a centrifugation force is used to control the disruption of 6 
the cell membranes for facilitated intracellular delivery. At the end of the process, the cell 7 
suspension is collected. 8 
 9 
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Figure 2. Cytosolic delivery by diamond nanoneedle arrays. (a) Fluorescence images of A549 8 
cells after delivery of FITC-Dextran (10,000 MW) under different conditions (no treatment, 9 
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incubation with FITC-Dextran, incubation with FITC-Dextran and diamond nanoneedle 1 
treatment).  Hoechst 33342 was used to stain the nucleic acid. Green signal indicates the 2 
fluorescence of FITC-Dextran. (b) Quantification of fluorescent intensity within the cells by 3 
using Image-J. (c) and (d) Cell viability of A549 cells under different conditions (no treatment, 4 
incubation with 0.2 μg ml-1 cisplatin (cisplatin-CT), treated with diamond nanoneedle arrays 5 
(ND) and incubation with 0.2 μg ml-1 cisplatin. MTT assays were conducted at 48 hours after 6 
incubation. (c) nanoneedle arrays treatment of cells for 30 seconds. (d) nanoneedle arrays 7 
treatment of cells for 5 minutes. (*p < 0.01) (e) The delivery of doxorubicin to MCF7/ADR 8 
cells with and without nanoneedle treatment. Flow cytometry analysis of the fluorescence 9 
intensities of doxorubicin were tested immediately after drug delivery. (f) Cell viabilities of 10 
MCF7/ADR cells treated with 1 μg ml-1 doxorubicin with the aid of diamond nanoneedles 11 
(Doxorubicin-ND) or without using nanoneedles (Doxorubicin-CT). Untreated MCF7/ADR 12 
cells were used as negative control. (*p < 0.01; NS: non-significant) 13 
14 
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Figure 3. (a) Viability of A549 cells treated with diamond nanoneedle arrays. Cell viability 3 
was detected by MTT assay. Untreated cells were used as a control group. (b) Genotoxicity 4 
assay and (c) cell membrane integrity analysis. After being treated by diamond nanoneedle 5 
arrays, A549 cells were cultured in 96-well plate for 3, 6 or 24 hours. DNA double-strand 6 
breaks were investigated by monoantibody pH2AX detection. The fluorescence intensity of 7 
pH2AX signal was detected by using a TRITC filter (EX/EM 555/565 nm). The integrity of 8 
plasma membrane was evaluated by image-iT DEAD Green viability staining. The 9 
fluorescence intensity was assessed by a FITC filter (EX/EM 488/515 nm). (d) Detection of 10 
Extracellular G6PD level in A549 cells treated with a nanoneedle array. A549 cells were 11 
treated with a nanoneedle array (ND) followed by culturing of 24 hours, and then the 12 
extracellular G6PD release was measured (EX/EM 530/590 nm). Cell culture medium alone 13 
and untreated cells were used as control groups. (*p < 0.01; NS: non-significant) 14 
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 1 
Figure 4. Flow cytometry analysis of apoptosis and necrosis of A549 cells. (a) Untreated cells; 2 
(b) Cells treated with a diamond nanoneedle array alone; (c) Cells incubated with 5 μg ml-1 of 3 
cisplatin for 24 hours. (d) Cisplatin was added to a cell suspension with a concentration of 5 4 
μg ml-1 and the suspension was applied to a diamond nanoneedle array for treatment for 5 5 
minutes. Subsequent, the cell suspension was collected and cultured in a 96-well plate for 24 6 
hours. The analysis was conducted after 24 hours incubation.  For all groups, A549 cells were 7 
stained and analysed by 488 nm excitation with 530/30 nm and 575/24 nm bandpass filters 8 
and collected by means of a standard 100 μl minute-1 collection rate. Early apoptotic cells are 9 
shown in the lower right quadrant, and necrotic cells are shown in the upper left quadrant. 10 
  11 
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 1 
Figure 5. Cytosolic delivery of calcein-AM and PI in A549 cells. (a) Calcein-AM (left) and 2 
PI (right) fluorescent images of living A549 cells when the chemicals were added at different 3 
time points after the cells being treated with nanoneedles. (b) Quantification of calcein-AM 4 
fluorescent intensity of different groups. (c) Quantification of PI fluorescent intensity at 5 
different time points. Untreated A549 cells were set as a control group. 6 
7 
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Figure 6. ROS content detection in A549 cells with nanoneedle array treatment. (a) After 3 
incubating for 12 or 24 hours, flow cytometry analysis was conducted to evaluate the ROS 4 
content in A549 cells. Cells treated with or without 1 μg ml-1 cisplatin (cDDP) addition and a 5 
nanoneedle array (ND) as indicated in the figure were stained with 5 μM CellROX Green 6 
reagent (EX/EM 485/520 nm).  (b) Fluorescence images of ROS in A549 cells with or 7 
without nanoneedle array treatment (ND). Hoechst 33342 was used to stain cell nucleus. The 8 
cells without nanoneedle array treatment were used as control group. 0 h means immediately 9 
after nanoneedle treatment. 10 
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Figure 7. Intracellular G6PD activity assay. Untreated A549 cells were used as control group. 3 
After being treated by a nanoneedle array platform (ND), A549 cells were cultured in 96-well 4 
plate for 3, 6, 12, and 24 hours as indicated. Then the cells were lysed and the activity of 5 
G6PD was measured in a microplate reader (EX/EM 530/590 nm). (*P < 0.01; NS: non-6 
significant) 7 
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Figure 8. Flow cytometry assay of mitochondrial membrane potential. (a) Untreated A549 2 
cells were used as positive control. (b) Untreated A549 cells with 50 μM cccp (carbonyl 3 
cyanide 3-chlorophenylhydrazone) were used as negative control. Following the nanoneedle 4 
array treatment, A549 cells were stained with 2 μM JC-1 immediately (c), or after 12 (d) or 24 5 
hours (e) incubation. Cells were analysed on flow cytometer using 488 nm excitation with 6 
530/30 nm and 585/42 nm band-pass emission filters. The intensity of green and red 7 
fluorescence intensities are shown as R2 and R3, respectively. 8 
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Figure 9. Schematic representation of the influence of diamond nanoneedle array treatment 2 
on the intracellular metabolic system. Following the diamond nanoneedle arrays penetration, 3 
the phosphatidylserine is exposed to the extracellular environment and can bind with Annexin 4 
V. The nanoneedle treatment leads to a significant decrease of mitochondrial membrane 5 
potential. As a result, a high content of ROS is produced under the increased oxidant stress. 6 
Under this oxidant environment, the activity of intracellular redox enzymes G6PD is aroused 7 
to counterbalance the high production of ROS. In the process, NADPH is synthesised and 8 
utilized by the glutathione (GSH) mediated antioxidant defence. 9 
